Search - tctmd.com

Displaying 121 - 140 of 519

Sort: Relevancy | Date

News Daily News

关于人工生物瓣膜血栓形成的新发现可影响监测和研究

Caitlin E. Cox

November 23, 2015

News Daily News

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

Caitlin E. Cox

November 23, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

Good News, Bad News Week for Watchman LAA Occluder

Shelley Wood

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Features

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Todd Neale

November 08, 2015

News Conference News AHA 2015

Is Watchman Cost-effective? That Depends Where You Look

Todd Neale

November 07, 2015

News Daily News

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Todd Neale

October 26, 2015

$Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?$

Presentation TCT 2015

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel

October 15, 2015

Presentation TCT 2015

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

Presentation TCT 2015

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: Carlo Briguori, Roxana Mehran

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

Data Gaps and Future Trial Pathways: Possible Study Designs for New Devices, Anticoagulation Ineligible Patients, and Comparative NOAC Data

Presenter: Nicole Ibrahim, Saibal Kar, Zoltan G. Turi

October 14, 2015

News Conference News TCT 2015

Manual Thrombectomy Does Not Improve Outcomes in High-Risk STEMI Patients

October 14, 2015

Presentation TCT 2015

TCT 77: Risk and Benefits of Triple Therapy in Patients Undergoing Percutaneous Coronary Stent Implantation Requiring Chronic Oral Anticoagulation A Meta-analysis of 12 Trials

Presenter: Lisa K. Jennings, Neal S. Kleiman, Lucia Barbieri

October 13, 2015

Presentation TCT 2015

PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy?

Presenter: George D. Dangas, Paul A. Gurbel, C. Michael Gibson

October 13, 2015

Presentation TCT 2015

Anticoagulation in the Periimplant Period (Pre, Peri, and Post): An Evidence-Based Analysis

Presenter: Maurice Buchbinder, Brian K. Whisenant, Sameer Gafoor

October 12, 2015

Advertisement

关于人工生物瓣膜血栓形成的新发现可影响监测和研究

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

Good News, Bad News Week for Watchman LAA Occluder

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

From Great to Greater: Innovation in Stent Technology Possible, Worth Pursuing

Is Watchman Cost-effective? That Depends Where You Look

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients?

MATRIX Trial Recap: Interaction Between Access Site and Antithrombin Choice in ACS

The REG1 Anticoagulation System: Lessons From Factor IX Inhibitor Using RNA Aptamer Technology

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Data Gaps and Future Trial Pathways: Possible Study Designs for New Devices, Anticoagulation Ineligible Patients, and Comparative NOAC Data

Manual Thrombectomy Does Not Improve Outcomes in High-Risk STEMI Patients

TCT 77: Risk and Benefits of Triple Therapy in Patients Undergoing Percutaneous Coronary Stent Implantation Requiring Chronic Oral Anticoagulation A Meta-analysis of 12 Trials

PCI and Atrial Fibrillation Anticoagulation: Triple or Dual Therapy?

Anticoagulation in the Periimplant Period (Pre, Peri, and Post): An Evidence-Based Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content